The tumor suppressor phosphatase and tensin homologue deleted from chromosome 10 (PTEN) gene is a negative regulator of the phosphatidylinositol-3-kinase (PI3K)/protein kinase B (Akt/PKB) signaling pathway. Overexpression of PTEN in cancer cells results in cell-cycle arrest and cell death through inhibition of PI3K. Caffeine, a xanthine analogue, is well known to enhance the cytocidal and growth-inhibitory effects of DNA-damaging agents such as radiation, UV light, and anticancer agents on tumor cells by abrogating DNA-damage checkpoints through inhibition of ataxia-telangiectasia-mutated (ATM), and ATM and Rad3-related (ATR) kinase activity. In this study, we demonstrate that treatment with a combination of adenovirus-mediated transfer of PTEN (Ad-PTEN) and caffeine synergistically suppressed cell growth and induced apoptosis in colorectal cancer cells but not in normal colorectal fibroblast cells. This synergistic effect was induced through abrogation of G 2 /M arrest, downregulation of the Akt pathway, and modulation of the p44/42MAPK pathway. Thus, combined treatment with Ad-PTEN and caffeine is a potential therapy for colorectal cancer.
T he phosphatase and tensin homologue deleted from chromosome 10 (PTEN) gene is a tumor-suppressor gene located on human chromosome 10q23. 3.
1 Frequent deletions and somatic mutations of PTEN have been reported in glioblastoma, endometrial cancer, prostate cancer, and small cell lung cancer. [2] [3] [4] [5] Overexpression of PTEN in cancer cells carrying mutant-or deletion-type PTEN inhibited cell proliferation and tumorigenicity via induction of cell-cycle arrest at G 1 and apoptosis. [6] [7] [8] [9] More recently, studies using ovarian, thyroid, and colorectal cancer cells that express wild-type PTEN (wt-PTEN) demonstrated that ectopic expression of PTEN resulted in growth inhibition and cell death. [9] [10] [11] Furthermore, we have recently demonstrated that ectopic expression of PTEN induced G 2 arrest and apoptosis in colorectal cancer cells that express wt-PTEN. 12 Most effective anticancer therapies are genotoxic agents that damage DNA and kill dividing cells rapidly. In addition to apoptosis, DNA damage induced by ionizing radiation (IR) or other insults triggers, in addition to apoptosis, cell-cycle checkpoint activation and subsequent cell-cycle arrest, enhancing the ability of cells to repair damaged DNA. 13, 14 The checkpoint may contribute to the development of drug resistance, a formidable limitation in current cancer treatment. If this is so, agents that over-ride cell-cycle checkpoints could be used to sensitize cells to killing by genotoxic drugs. 15 Proof of this concept has arisen from studies with caffeine. Caffeine, a methylxanthine, is known to have a broad range of biochemical and physiological activities. 16 Caffeine is well documented to modulate carcinogenesis at various organ sites, including liver, skin, lung, and mammary gland, in animals treated with carcinogens. 16 Treatment with caffeine significantly decreases lung tumor formation in mice treated with the precursors of N-nitrosomorpholine or with N-nitrosodiethylamine, 4-nitroquinoline-l-oxide, or urethane. [17] [18] [19] [20] Caffeine seems to invariably protect against lung tumorigenesis in both mice and rats treated with carcinogens. In contrast, caffeine can either stimulate or inhibit carcinogen-induced mammary gland tumorigenesis, depending on the species and strains and the cellcycle phases during which it is administered. 21 In recent years, caffeine has been shown to inhibit gastric tumor promotion by sodium chloride in rats, 22 despite enhancing the pancreatic tumorigenesis caused by N-nitrosobis (2-oxopropyl) amine in hamsters when administered during the postinitiation phase. 23 Caffeine also protects against UV light-induced skin tumorigenesis. 24, 25 More recent studies have demonstrated that caffeine is an inhibitor of cell-cycle checkpoints, causing disruption of DNA damage at checkpoints (including the G 2 /M checkpoint) through inhibition of ataxia-telangiectasia-mutated (ATM), and ATM and Rad3-related (ATR) kinase activity and sensitizes tumor cells to IR, cisplatin, and other genotoxic agents. [26] [27] [28] [29] Although the tumor-suppressive effect of PTEN and the sensitization to various genotoxic agents by caffeine have been studied in a wide variety of cancer cells, caffeine enhancement of PTENinduced apoptosis has not been previously studied. Therefore, we tested whether treatment with a combination of adenovirus-mediated transfer of PTEN (Ad-PTEN) and caffeine would enhance the therapeutic effect. In the present study, we demonstrate that treatment with combinations of Ad-PTEN and caffeine induces synergistic suppression of cell growth and apoptosis selectively in colorectal cancer cells, but not in normal cells, through abrogation of G 2 /M arrest, downregulation of the Akt pathway, and modulation of the p44/42MAPK pathway. These results suggest that treatment with a combination of Ad-PTEN and caffeine can be an effective gene therapeutic strategy for human colorectal cancer.
Materials and methods

Cell lines and cell culture
Colorectal cancer cell lines SW480 and DLD-1, normal colon fibroblast cell line CCD-18Co, and prostate cancer cell lines DU145 and LNCaP were obtained from the American Type Culture Collection (Rockville, MD). Colon cancer cell lines HCT116 Á p53 ðþ=þÞ and HCT116 Á p53 ðÀ=ÀÞ were gifts from Dr. Bert Vogelstein (Johns Hopkins Medical Oncology Center, Baltimore, MD). All cell lines were grown in RPMI 1640 medium, except SW480 and CCD-18Co, which were maintained in Dulbecco's modified Eagle's medium and in modified essential medium in Earle's balanced salt solution with nonessential amino acids, respectively. The growth medium was supplemented with 10% fetal bovine serum, antibiotics, and l-glutamine (Gibco -BRL, New York, NY).
Construction of recombinant adenoviral vector
Construction and production of the recombinant adenoviral vectors carrying PTEN (Ad-PTEN) or the luciferase gene (Ad-Luc) have been described elsewhere. 30 
XTT assay
Inhibition of tumor cell growth by treatment with combinations of Ad-PTEN, Ad-Luc, or IR and caffeine was analyzed by quantitatively determining cell viability using an improved XTT assay (Roche Molecular Biochemicals, Indianapolis, IN). 31 Cells were plated in 96-well microtiter plates at densities of 2 Â 10 3 -6 Â 10 3 cells per well in 100 ml of medium. At 24 h after the cells were plated, 50-ml aliquots of medium containing varying concentrations of Ad-PTEN or Ad-Luc were added to each well, or cells were exposed to varying doses of IR after 30 minutes of exposure to 100-ml aliquots of medium containing varying concentrations of caffeine. After 3 hours of infection with Ad-PTEN or Ad-Luc at various multiplicity of infection (MOI) units (i.e., viral particles [vp]/cell), 50-ml aliquots of medium containing varying concentrations of caffeine were added into each well. Cells were then incubated at 371C in a humidified atmosphere containing 5% CO 2 . At 3 days after incubation, cell growth and viability were quantified by XTT assay. Briefly, the culture medium was removed, and 150 ml of XTT reaction mixture was added into each well with fresh medium at a final concentration of 0.3 mg/ml/well. Cells were then incubated for 2 hours at 371C. The absorbance was measured at a wavelength of 450 nm against a reference wavelength of 630 nm in a microplate reader (Model ELX808; Bio-Tek Instruments, Inc., Winooski, VT). Percentage cell viability was calculated in terms of the absorbancy in treated cells relative to the absorbancy in untreated control cells. Experiments were repeated at least three times for each treatment in each individual experiment.
Isobologram analysis
The combination effects were analyzed by a modified isobologram method. 32 Briefly, three isoeffect curves (modes I, IIA, and IIB), which were derived from each growth-inhibition curve, were drawn; the total area enclosed by these three lines represented an ''envelope of additivity.'' Actual IC 50 values were obtained and plotted on the envelope. If the experimentally observed IC 50 was plotted on the left side of the envelope, the combination was considered to show a supra-additive (synergistic) interaction. If it was plotted within the envelope, the combination was regarded as additive, and if it was plotted on the right of the envelope and within the dotted-line square, the combination was considered to be subadditive. If the observed IC 50 was plotted outside the square, the combination was considered to be protective.
Gene transduction
Preliminary experiments using an adenoviral vector carrying the green fluorescent protein (Ad-GFP) showed that, at an MOI of 5000 vp/cell, the adenovirus can infect 99.3% of HCT116 p53 ðþ=þÞ and 81.9% of CCD-18Co cells and more than 80% of other cells (data not shown) by 24 hours after infection. On the basis of these results, we used Ad-PTEN or Ad-Luc at an MOI of 5000 vp/cell in all subsequent experiments.
Cell-cycle analysis
Cells were seeded in 10-cm culture dishes (5 Â 10 5 -10 Â 10 5 cells per dish) and treated with 2 mM caffeine 3 hours after infection with Ad-PTEN or Ad-Luc, or treated with 20 mM of LY294002 (PI3K inhibitor) or 10 mM U0126 (MEK1/2 inhibitor) (Cell Signaling Technology, Beverly, MA). To produce DNA damage, cells were exposed to 2.0 Gy IR 30 minutes after treatment with caffeine. At specified times after treatment, cells were harvested by trypsinization, washed once with ice-cold phosphate-buffered saline (PBS), fixed with 70% ethanol, and stored at À201C. Cells were then washed twice with ice-cold PBS and treated with RNase (30 minutes at 371C, 500 U/ml) (Sigma Chemicals, St Louis, MO), and DNA was stained with 50 mg/ml propidium iodide (BoehringerMannheim, Indianapolis, IN). DNA contents and cellcycle phases were analyzed on a fluorescence-activated cell sorter (FACScan, EPICS XL-MCL; Beckman Coulter, Fullerton, CA).
Apoptotic staining
Cells were seeded in six-well tissue culture dishes at a density of 1 Â 10 5 cells per well and treated with 2 mM caffeine or PBS as a mock control 3 hours after infection of Ad-PTEN. At 72 hours after infection, cells were analyzed for apoptosis using Hoechst 33258 staining (Sigma Chemicals). Apoptotic cells were identified via apoptotic body and/or chromosome condensation.
Western blot analysis
Cells were plated at densities of 5 Â 10 5 -10 Â 10 5 in 10-cm dishes overnight. They were treated with 20 mM LY294002 or 10 mM U0126 alone, with 2 mM caffeine 3 hours after infection with Ad-PTEN or Ad-Luc, or exposed to 2.0 Gy IR at 30 minutes after treatment with caffeine. Cells were incubated for the indicated times at 371C and then collected, and whole-cell lysates prepared. The cell lysates were analyzed for the expression of various proteins by Western blot analysis. The blots were reprobed using antibodies against b-actin (Sigma Chemicals) to ensure equal loading and transfer of proteins. The following primary antibodies were purchased and used at 1:500 or 1:1000 dilution: PTEN, Cdc2, p53 (Bp53-12), and p27
Kip1 , (Santa Cruz Biotechnology, Santa Cruz, CA); Cdc25C, phospho-Akt, and phospho-p44/42MAPK (Cell Signaling Technology); cyclin B1 (Neo Markers, Fremont, CA); and p21 WAF1 (Oncogene Research Products, Boston, MA).
Results
Combined treatment with Ad-PTEN and caffeine produces a synergistic effect in colorectal cancer cells
To observe the effect of the combination of Ad-PTEN and caffeine, four colorectal cancer cell lines (HCT116 p53 ðþ=þÞ, HCT116 p53 ðÀ=ÀÞ, SW480, DLD-1) and one normal colon cell line (CCD-18Co) were analyzed 72 hours after treatment (Fig 1a, b) . All of the experiments were repeated at least three times for each cell line. At the IC 50 concentration for each cell line, combination of Ad-PTEN and caffeine produced a complete synergistic effect in HCT116 p53 ðþ=þÞ and SW480 cells but a boundary effect between addition and synergy in HCT116 p53 ðÀ=ÀÞ and DU145 cells. The observed data points were distributed either within the additive envelope or scattered around the boundary between the additive and the synergistic areas (Fig 1a) . However, a protective effect was observed in CCD-18Co cells under these treatment conditions (Fig 1b) . An additive effect was also observed in LNCaP cells treated with Ad-PTEN and caffeine (data not shown). To further confirm that the observed synergistic effect was specific, we tested the effects of a combination of Ad-Luc and caffeine in HCT116 p53 ðþ=þÞ cells (Fig 1c) . Unlike Ad-PTEN plus caffeine, Ad-Luc plus caffeine produced a boundary effect between additive and protective effects. These results indicate that treatment with a combination of Ad-PTEN and caffeine specifically induces a synergistic effect in tumor cells but not in normal cells (Table 1 ). Treatment with a combination of Ad-PTEN and caffeine induces apoptosis in colorectal cancer cells 12, 30 In contrast, treatment with a combination of Ad-PTEN or Ad-Luc and caffeine yielded dramatically lower numbers of HCT116 p53 ðþ=þÞ and CCD18-Co cells that underwent G 2 /M-phase arrest than treatment with Ad-PTEN or Ad-Luc alone. Treatment with caffeine alone yielded no significant decrease in the number of cells in the G 2 /M phase when compared to control cells treated with PBS. However, the number of cells in G 2 /M phase was significantly higher (Po.01) in cells treated with Ad-PTEN and caffeine than in cells treated with AdLuc and caffeine.
Signaling pathways regulated by PTEN overexpression and caffeine treatment in colorectal cancer cells and normal cells
To investigate the mechanism through which PTENinduced G 2 /M arrest is abrogated by caffeine, proteins related to the G 2 /M and G 1 cell-cycle checkpoints were evaluated. In this analysis, HCT116 p53 ðþ=þÞ and CCD18-Co cells were treated with 2 mM caffeine, PBS, Ad-PTEN or Ad-Luc alone, or a combination of Ad-PTEN or Ad-Luc and caffeine. Total cell lysates were prepared 48 hours after treatment and analyzed by Western blot analysis. Cells treated with Ad-PTEN, or Ad-PTEN and caffeine, demonstrated exogenous PTEN protein expression that resulted in inhibition of pAKT in both cell types (Fig 4a) . However, the PTEN protein expression was significantly increased in HCT116 p53 ðþ=þÞ cells, but not in CCD18-Co cells, when treated with the combination of Ad-PTEN and caffeine. Treatment with Ad-PTEN alone increased expression of p53, p21 and p27 and decreased expression of both phosphorylated and nonphosphorylated Cdc25C when compared to cells treated with PBS or Ad-Luc. However, no change in the expression of phospho-Chk1 and phospho- To further determine the underlying mechanism through which treatment with a combination of Ad-PTEN and caffeine produced a synergistic effect, we examined the phosphorylation status of p44/42MAPK and FAK, which PTEN inhibits mainly through dephosphorylation. 34, 35 Although phospho-p44/42MAPK expression was not changed by Ad-PTEN treatment alone, it was significantly increased in HCT116 p53 ðþ=þÞ but not in by treatment with the combination of Ad-PTEN and caffeine (Fig 4b) . No significant change in phosphop44/42MAPK was observed in CCD18-Co cells when treated with Ad-PTEN and caffeine. Therefore, to determine whether the synergistic effect of Ad-PTEN and caffeine in HCT116 p53 ðþ=þÞ was due to increased phosphorylation of p44/42MAPK, we used FACS analysis to investigate phosphorylation status of p44/42MAPK and apoptotic ratio by treating cells with 10 mM U0126, which is a MEK1/2 inhibitor. Treatment with Ad-PTEN, caffeine, and U0126 significantly increased the phosphorylation status of p44/42MAPK; however, expression of p44/42MAPK was less than in cells treated with Ad-PTEN and caffeine only (Fig 4b) . In contrast, FACS analysis showed a significantly greater apoptotic ratio (39.35%) (Po.01) in cells treated with a combination of Ad-PTEN, caffeine, and U0126 than in cells treated with Ad-PTEN and caffeine only (13.05%; Fig 4c) . No significant change in the expression of phospho-FAK was observed among the treatment groups 48 hours after treatment (data not shown), although phospho-FAK was decreased at later time points in HCT116 p53 ðþ=þÞ cells treated with caffeine alone or with Ad-PTEN and caffeine (data not shown).
Comparison of the combined effects of Ad-PTEN and caffeine treatment and the combined effects of radiation and caffeine in colorectal cancer cells
To test whether caffeine can abrogate G 2 /M phase arrest induced by other agents such as IR, we evaluated the combined effects of radiation treatment and caffeine and compared those effects to the effects of PTEN and caffeine in HCT116 p53 ðþ=þÞ cells. Cells were treated with Ad-PTEN (5000 vp/cell) and caffeine or IR (2 Gy) and caffeine and subjected to cell-cycle analysis 48 hours after treatment. Cells treated with Ad-PTEN (51.4%) or (Fig  5a, b) . When these treatments were combined with caffeine, however, the numbers of cells in the G 2 /M phase in the Ad-PTEN-treated (27%) and IR-treated (23.6%) groups were significantly decreased (Po.01), with concomitant increases in the number of cells in G 1 phase (Fig 5a, b) . Note, although a shift in the number of cells from G 2 /M phase to G 1 phase was observed when treated with Ad-PTEN or IR plus caffeine, there was no significant increase in the number of cells in the sub-G 1 phase. This is probably due to the early time point tested since an increase in the number of apoptotic cells (sub-G 1 ) was observed at later time points (472 hours; data not shown). These results indicate that caffeine abrogates G 2 / M arrest induced by various therapeutic agents.
To further investigate whether treatment with the combination of IR and caffeine produced a synergistic effect similar to that observed with Ad-PTEN and caffeine, HCT116 p53 ðþ=þÞ cells were treated with PBS, Ad-PTEN, IR, or a combination of Ad-PTEN or IR and caffeine. At 72 hours after treatment, cells were analyzed by XTT assay for synergism using isobologram analysis and by FACS to determine the apoptotic ratio. Combination treatment with IR and caffeine produced an additive effect (Fig 6a) . FACS analysis 72 hours after treatment revealed no significant difference in the apoptotic ratio in cells treated with a combination of Ad-PTEN and caffeine and in cells treated with a combination of IR and caffeine (Fig 6b) . After 120 hours, however, the apoptotic ratio was significantly higher in cells treated with a combination of Ad-PTEN and caffeine (99%), than in cells treated with IR and caffeine (15.45%). Furthermore, we observed induction of phosphorylated p44/42MAPK expression when cells were subjected to IR treatment alone or to a combination of IR and caffeine (Fig 6c) . Induction of p44/42MAPK was higher in cells treated with IR and caffeine and was similar to that seen when cells were treated with Ad-PTEN and caffeine.
Discussion
In the present study, we investigated the effects of treatment with a combination of Ad-PTEN and caffeine in colorectal cancer cells that express wt-PTEN. Treatment with this combination successfully produced complete synergistic suppression and induced apoptosis to a significantly higher extent in colorectal cancer cells (HCT116 p53 ðþ=þÞ) than in normal colorectal cells (CCD-18Co). To further compare the effects of this combination in cells that express wild-type p53 (wt-p53) and cells that express mutant p53 (mt-p53), we used HCT116 p53 ðþ=þÞ and HCT116 p53ðÀ=ÀÞ cells. To compare the effects of this combination in wt-PTEN cells and in mutant-type PTEN cells, we used prostate cancer cell lines LNCaP, expressing mutated PTEN, and DU145, expressing wt-PTEN. We showed not only that overexpression of PTEN significantly suppressed growth and induced apoptosis in tumor cells compared to normal cells, but also that treatment with a combination of overexpression of PTEN and caffeine produces a synergistic inhibitory effect in cancer cells expressing wt-PTEN (Table 1) . Although in the present study we have tested two prostate cell lines that differ in their PTEN status to Figure 3 Induction and abrogation of G 2 /M cell-cycle arrest due to overexpression of PTEN and treatment with caffeine. (a) HCT116 Á p53 ðþ=þÞ colorectal cancer cells and (b) CCD-18Co normal colorectal fibroblast cells were treated with PBS, Ad-Luc, Ad-PTEN, caffeine, combinations of caffeine with Ad-Luc or Ad-PTEN, or 20 mM LY294002. Cells were harvested 72 hours after treatment and cell-cycle analysis was performed by using flow cytometry. In total 20,000 events were captured for each treatment, and the data are shown as histograms. The cell-cycle phase is represented on the X-axis. Data were generated in duplicate; the average values are shown. Bars denote standard error (SE).
support our findings on the ability of Ad-PTEN plus caffeine treatment to induce a synergistic effect in colorectal cancer cells that are wt-PTEN, a note of caution is that these cells may have additional differences apart for their differences in the PTEN status. Furthermore, this synergistic inhibitory effect was independent of endogenous p53 status. This contrasts with previous reports demonstrating that p53-null or -mutant cells were more sensitive to caffeine-induced radiosensitization than wt-p53 cells. [36] [37] [38] It is possible that the results of previous studies are supported by the observation that p53 plays an important role in DNA damage-induced cell-cycle checkpoints and contributes to the prevention of polyploidy formation. [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] More recent studies have demonstrated that PTEN protects p53 from Mdm2, allows cells to respond to damage or mutation with an apoptotic response, and sensitizes cancer cells to chemotherapy. 41, 43 In fact, Tsuchiya et al 43 showed that the synergistic antitumor effect of caffeine and cisplatin was enhanced by reintroduction of wild-type p53 into human osteosarcoma cells. Thus, the role of p53 remains controversial. The mechanism by which the synergistic inhibitory effect was produced was determined by cell-cycle analysis. Treatment with Ad-PTEN alone resulted in G 2 /M-phase arrest of both tumor cells and normal cells, while treatment with caffeine alone resulted in G 1 arrest. Induction of G 2 /M arrest by Ad-PTEN in cells that express wt-PTEN is not surprising and is in agreement with results of our recent studies. 12, 30 However, PTEN induction of G 2 /M phase was abrogated by caffeine in both tumor and normal cells. Caffeine-induced G 1 was significantly more common in normal CCD-18Co cells than in HCT116 p53 ðþ=þÞ cells, suggesting that caffeine had a stronger inhibitory effect on proliferation of CCD18Co cells proliferation than on that of HCT116 p53 ðþ=þÞ cells. Interestingly, the increased inhibitory effect of caffeine in CCD-18Co cells did not result in any increase in the number of apoptotic cells, even on day 5 after treatment (data not shown).
To further understand the mechanism by which the G 2 / M checkpoint can be altered by Ad-PTEN, we analyzed the level of Cdc25C protein expression. In G 2 /M phase, active Cdc25C phosphatase dephosphorylates Cdc2 on both threonine-14 and tyrosine-15 and then activates Cdc2/cyclin B1 complexes, leading to progression of the cells to M phase. In response to DNA damage or inhibition of DNA replication, however, inhibitory phosphorylation of cdc2 remains, and the cells are arrested at G 2 phase. [44] [45] [46] [47] Our data demonstrate that Cdc25C expression was downregulated following Ad-PTEN treatment in both tumor cells and normal cells. ATM and ATR are proximal components of DNA damage-induced cell-cycle checkpoint pathways, and activated ATM and ATR phosphorylate Chk2 and Chk1, respectively. Therefore, DNA damage leads to activation of two related protein kinases, Chkl and Chk2, which then phosphorylate the Cdc25C phosphatase on serine-216. 42 p53 is also required for G 2 arrest in response to DNA damage; 48 therefore, we assayed 14-3-3s, GADD45, and p21 WAF1 , which reside downstream of p53 and are associated with modulation of Cdc2 phosphorylation and G 2 /M-phase arrest. 49 Ad-PTEN increased p53 and 14-3-3s expression, but not GADD45 (data not shown) or p21 WAF1 , in HCT116 p53 ðþ=þÞ colorectal cancer cells compared with controls. We next evaluated the effect of caffeine, an inhibitor of ATM and ATR that abrogates the G 2 checkpoint as described, on Figure 5 Abrogation of G 2 /M cell-cycle arrest due to overexpression of PTEN or ionized radiation combined with caffeine. HCT116 Á p53 ðþ=þÞ colorectal cancer cells were (a) treated with Ad-PTEN or combination of Ad-PTEN and caffeine, or (b) exposed to 2 Gy IR or a combination of IR and caffeine. Cells were harvested 24 hours after treatment and cell-cycle analysis was performed by using flow cytometry. In total, 20,000 events were captured for each treatment, and the data are shown as histograms. The cell-cycle phase is represented on the X-axis. Data were generated in duplicate; the average values are shown. Bars denote standard error (SE). -associated proteins (p53,  p21 WAF1 , p27 Kip1 , both phosphorylated and nonphosphorylated Cdc25C, cyclin B1, and Cdc2), but we were not able to detect dephosphorylation of Chkl and Chk2 induced by caffeine. These results suggest that Ad-PTEN induced G2/M arrest in cancer cells carrying wt-PTEN occurs by inhibition of Cdc25C and support the findings of our recent studies. 12, 33 Thus, the main targets of PTEN in cells carrying wt -PTEN may be different from those in cells carrying mutant-or deletion-type PTEN. We suggest that, on the basis of the status of endogenous PTEN, cells could be arrested at either G 1 or G 2 phase. Similarly, the downstream pathways may be different. However, the exact mechanism by which PTEN causes this difference in cell-cycle arrest is unclear and remains to be investigated.
Further analysis of the underlying mechanism of the observed synergistic inhibitory effect of Ad-PTEN and caffeine treatment in tumor cells demonstrated inhibition of the Akt pathway and upregulation of the p44/ 42MAPK pathway. However, inhibition of Akt was observed in both tumor and normal cells. In contrast, activation of p44/42MAPK was observed only in tumor cells but not in normal cells. However, activation of p44/ 42MAPK appeared to be associated with cytoprotective functions as previously reported, 50 since treatment with a combination of Ad-PTEN, caffeine, and MEK1 inhibitor UO126 resulted in lower expression of p44/42MAPK and a significantly higher apoptotic rate than treatment with Ad-PTEN and caffeine only. Alternatively, the increased PTEN protein expression observed in tumor cells, but not in normal cells, when treated with Ad-PTEN and caffeine could be responsible for the observed synergistic inhibitory effect. Whatever the underlying mechanism maybe, the present study demonstrates that the combination treatment of Ad-PTEN and caffeine exerts synergistic inhibitory effect in tumor cells but not in normal cells. To further test whether the effect and the function of PTEN as an growth inhibitor and apoptotic inducer are similar to other agents, HCT116 p53 ðþ=þÞ cells were treated with Ad-PTEN or IR. Cell-cycle analysis showed that IR treatment induced G 2 /M arrest and caffeine abrogated the G2/M arrest similar to that observed with Ad-PTEN and caffeine treatment. However, associated with the abrogation of the G2/M arrest, an increase in the number of apoptotic cells was not observed. This is due to the fact that the cell-cycle analysis was performed at early time points (48 hours). Analysis at later time points demonstrated increased number of apoptotic cells (data not shown). A major difference between PTEN and IR treatment, however, was in the expression of p44/ 42MAPK. IR induced p44/42MAPK expression but Ad-PTEN did not, while caffeine enhanced its expression. These results suggest that PTEN has an inhibitory effect on phospho-p44/42MAPK, but IR does not, and caffeine may enhance this kinase activity because of cytoprotective functions and/or mitogenic or differentiation-related stimuli. 51, 52 Furthermore, combined treatment with IR and caffeine produced an additive effect, but not synergy, and induced significantly fewer apoptotic cells than treatment with Ad-PTEN and caffeine on day 5 after treatment. These results suggest that PTEN is a more effective therapeutic agent when combined with caffeine. In summary, the present study demonstrates that treatment with a combination of Ad-PTEN and caffeine produces a synergistic therapeutic effect and selectively induces apoptosis in colorectal cancer cells, especially in cancer cells that express wt-PTEN, but not in normal cells. Thus, combined treatment with Ad-PTEN and caffeine may offer a therapeutic strategy for patients with colorectal cancer.
